Deciphera Pharmaceuticals LLC Valuation
Based on Macroaxis valuation methodology, the firm cannot be evaluated at this time. Deciphera Pharmaceuticals prevailing Real Value cannot be determined due to lack of data. The current price of Deciphera Pharmaceuticals is $0.0. Our model computes the value of Deciphera Pharmaceuticals from reviewing the firm fundamentals such as Operating Margin of (1.09) %, profit margin of (1.09) %, and Current Valuation of 1.97 B as well as analyzing its technical indicators and probability of bankruptcy.
Deciphera Pharmaceuticals Total Value Analysis
Deciphera Pharmaceuticals LLC is currently projected to have valuation of 1.97 B with market capitalization of 2.21 B, debt of 25.88 M, and cash on hands of 383.85 M. Please note that valuation may be misleading and is a subject to auditing or accounting errors. We encourage investors to vigilantly validate all of the Deciphera Pharmaceuticals fundamentals before making equity appraisal based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
1.97 B | 2.21 B | 25.88 M | 383.85 M |
Deciphera Pharmaceuticals Investor Information
About 28.0% of the company shares are held by company insiders. The company recorded a loss per share of 2.21. Deciphera Pharmaceuticals had not issued any dividends in recent years. Based on the key indicators related to Deciphera Pharmaceuticals' liquidity, profitability, solvency, and operating efficiency, Deciphera Pharmaceuticals LLC is not in a good financial situation at the moment. It has a very high risk of going through financial straits in March.Deciphera Pharmaceuticals Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Deciphera Pharmaceuticals has an asset utilization ratio of 34.49 percent. This signifies that the Company is making $0.34 for each dollar of assets. An increasing asset utilization means that Deciphera Pharmaceuticals LLC is more efficient with each dollar of assets it utilizes for everyday operations.Deciphera Pharmaceuticals Ownership Allocation
Deciphera Pharmaceuticals holds a total of 86.48 Million outstanding shares. The majority of Deciphera Pharmaceuticals LLC outstanding shares are owned by other corporate entities. These outside corporations are usually referred to as non-private investors looking to obtain positions in Deciphera Pharmaceuticals to benefit from reduced commissions. Consequently, institutional investors are subject to a different set of regulations than regular investors in Deciphera Pharmaceuticals. Please pay attention to any change in the institutional holdings of Deciphera Pharmaceuticals LLC as this could imply that something significant has changed or is about to change at the company. Also note that almost four hundred fourty-one thousand twenty-eight invesors are currently shorting Deciphera Pharmaceuticals expressing very little confidence in its future performance.Deciphera Pharmaceuticals Profitability Analysis
The company reported the previous year's revenue of 163.36 M. Net Loss for the year was (194.94 M) with loss before overhead, payroll, taxes, and interest of (62.55 M).Deciphera Pharmaceuticals Growth Indicators
Growth stocks usually refer to those companies expected to grow sales and earnings faster than the market average. Growth stocks typically don't pay dividends, often look expensive, and usually trading at a high P/E ratio. Nevertheless, such valuations could be relatively cheap if the company continues to grow, which will drive the share price up. However, since most investors are paying a high price for a growth stock, based on expectations, if those expectations are not fully realized, growth stocks can see dramatic declines.
| Common Stock Shares Outstanding | 85.1 M |
Check out Investing Opportunities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in american community survey. You can also try the Share Portfolio module to track or share privately all of your investments from the convenience of any device.
Other Consideration for investing in Deciphera Stock
If you are still planning to invest in Deciphera Pharmaceuticals check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Deciphera Pharmaceuticals' history and understand the potential risks before investing.
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities |